Abstract
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic disabling disease. However, there is a lack of an adequate and specific health measurement instrument validated and with good performance to assess their degree of physical disability. This led us to carry out this study and to evaluate the performance of Fiocruz's National Institute of Infectious Diseases (IDS) disability scale, a specific instrument for HAM/TSP. Ninety-two HAM/TSP patients participated in the study. One researcher applied the IDS, IPEC scale, Disability Status Scale (DSS), Expanded DSS (EDSS), Osame scale, Beck Depression Inventory, and the WHOQOL-BREF questionnaire. In parallel, blindly, and separately, other researchers applied the IDS. An inter-rater reliability analysis of the IDS, correlation analysis with the other scales, and depression and quality of life questionnaires were performed. The applicability of the IDS was also evaluated. The IDS showed high reliability in all scores. The inter-rater reliability test for the total IDS score was 0.94 (0.82-0.98) on its four dimensions. The scale adequately indicated the different degrees of disability, presenting a distribution similar to normal. There was a high correlation with the other scales (Spearman coefficients > 0.80, p < 0.001). The scale had good acceptance among users and a short application time. IDS for HAM/TSP was reliable, consistent, easy, and fast to use. It can be used for both prospective evaluations and clinical trials. The present study supports the IDS as a valid instrument to measure disability in patients with HAM/TSP compared to previously used scales.
Similar content being viewed by others
Data availability
The anonymized data supporting this study's findings are available from the corresponding author upon reasonable request.
Change history
30 November 2023
A Correction to this paper has been published: https://doi.org/10.1007/s13365-023-01188-2
References
Alreck PL, Settle RB (2004) The survey research handbook, 3rd edn. McGraw-Hill/Irwin, Boston
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders -DSM-5, 5th edn. Washington, DC
Araujo AQC, Silva MTT (2006) The HTLV-1 neurological complex. Lancet Neurol 5:1068–1076. https://doi.org/10.1016/S1474-4422(06)70628-7
Castro N, Oliveira P, Freitas D et al (2005) Erectile dysfunction and HTLV-I infection: a silent problem. Int J Impot Res 17:364–369. https://doi.org/10.1038/sj.ijir.3901335
Costa D, Castro N, Tannus M et al (2011) Neurological disability in HTLV-1 infected individuals according to the initial clinical presentation: cohort study. Retrovirology 8:A62. https://doi.org/10.1186/1742-4690-8-S1-A62
Eisen M, Ware JE, Donald CA, Brook RH (1979) Measuring components of children’s health status. Med Care 17:902–921. https://doi.org/10.1097/00005650-197909000-00003
Fleck MP, Louzada S, Xavier M et al (2000) Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Saude Publica 34:178–183. https://doi.org/10.1590/s0034-89102000000200012
Franzoi AC, Araújo AQC (2007) Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP). Spinal Cord 45:64–68. https://doi.org/10.1038/sj.sc.3101919
Gascón MRP, Capitão CG, Casseb J et al (2011) Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients. Braz J Infect Dis 15:578–582. https://doi.org/10.1590/s1413-86702011000600013
Gorenstein C, Andrade L (1996) Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res 29:453–457
Gorenstein C, Andrade LHSG de (1998) Inventario de depressao de Beck: propriedades psicometricas da versao em portugues. Rev psiquiatr clín (São Paulo) 245–50
Hobart J, Freeman J, Thompson A (2000) Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 123(Pt 5):1027–1040. https://doi.org/10.1093/brain/123.5.1027
Khanna D, Tsevat J (2007) Health-related quality of life–an introduction. Am J Manag Care 13(Suppl 9):S218-223
Koo TK, Li MY (2016) A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med 15:155–163. https://doi.org/10.1016/j.jcm.2016.02.012
Kurtzke JF (1955) A new scale for evaluating disability in multiple sclerosis. Neurology 5:580–583. https://doi.org/10.1212/wnl.5.8.580
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452. https://doi.org/10.1212/wnl.33.11.1444
Lima M, a. SD, Bica RBS, Araújo AQC (2005) Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. Journal of Neurology, Neurosurgery & Psychiatry 76:294–296. https://doi.org/10.1136/jnnp.2004.035709
Martin F, Castro H, Gabriel C et al (2012) Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis. PLoS Negl Trop Dis 6:e1675. https://doi.org/10.1371/journal.pntd.0001675
McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4:293–307. https://doi.org/10.1007/BF01593882
McHorney CA, Ware JE, Lu JF, Sherbourne CD (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40–66. https://doi.org/10.1097/00005650-199401000-00004
Olindo S, Cabre P, Lézin A et al (2006) Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 63:1560–1566. https://doi.org/10.1001/archneur.63.11.1560
Oliveira P, de Castro NM, Carvalho EM (2007) Urinary and sexual manifestations of patients infected by HTLV-I. Clinics 62:191–196. https://doi.org/10.1590/S1807-59322007000200015
Osame M (1990) Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Human Retrovirology: HTLV 1st edn. William Blattner, New York, p 484
Osame M, Janssen R, Kubota H et al (1990) Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 28:50–56. https://doi.org/10.1002/ana.410280110
Portney LG, Watkins MP (2015) Foundations of clinical research: applications to practice, 3rd edition, [revised]. Pearson/Prentice Hall, Upper Saddle River, N.J
Schmidt F, Oliveira AL, Araujo A (2012) Development and validation of a neurological disability scale for patients with htlv-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): The IPEC-1 Scale (P03.258). Neurology 78:P03.258-P03.258
Sharrack B, Hughes RA (1996) Clinical scales for multiple sclerosis. J Neurol Sci 135:1–9. https://doi.org/10.1016/0022-510x(95)00261-y
Sharrack B, Hughes RA, Soudain S, Dunn G (1999) The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 122(Pt 1):141–159. https://doi.org/10.1093/brain/122.1.141
Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428. https://doi.org/10.1037//0033-2909.86.2.420
Silva MTT, Espíndola OM, Leite AC et al (2017) Isolated bladder dysfunction in human T lymphotropic virus type 1 infection: 10 years of follow-up. J Neurol Neurosurg Psychiatry 88:278–279. https://doi.org/10.1136/jnnp-2016-314606
Silva MTT, Mattos P, Alfano A, Araújo AQ-C (2003) Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls. J Neurol Neurosurg Psychiatry 74:1085–1089
Souza F dos S, Freitas NL, Gomes YCP et al (2021) Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression. Front Immunol 12
Stewart AL, Ware JE (eds) (1992) Measuring functioning and well-being: the medical outcomes study approach. Duke University Press, Durham
Tavares IR, Franzoi AC, Araújo AQ-C (2010) Low-back pain in HTLV-I-associated myelopathy/tropical spastic paraparesis: nociceptive or neuropathic? Spinal Cord 48:134–137. https://doi.org/10.1038/sc.2009.83
Wang Y-P, Gorenstein C (2013) Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry 35:416–431. https://doi.org/10.1590/1516-4446-2012-1048
World Health Organization. Division of Mental Health (1996) WHOQOL-BREF : introduction, administration, scoring and generic version of the assessment : field trial version, December 1996. World Health Organization
Yamano Y, Nagai M, Brennan M et al (2002) Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99:88–94. https://doi.org/10.1182/blood.v99.1.88
Acknowledgments
We are grateful to all patients who participated in the study.
Funding
ESFC was partly funded by the Brazilian National Council for Scientific and Technological Development (CNPq - 307045/2016-1).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study's conception and design. Material preparation, data collection, and analysis were performed by Felipe R Schmidt, Evandro SF Coutinho, Marco A Lima, Marcus TT Silva, Ana CCB Leite, Igor O Fonseca, and Abelardo QC Araujo. The first draft of the manuscript was written by Felipe R Schmid and Abelardo QC Araujo, and all authors commented on previous versions. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Disclosures
The authors report no disclosures relevant to the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix 1 The INI Disability Scale (IDS)
Appendix 1 The INI Disability Scale (IDS)
THE NATIONAL INSTITUTE OF INFECTIOUS DISEASES DISABILITY SCALE (IDS) FOR HAM/TSP |
---|
MOTOR SCORE: GAITa 0. Normal 1. Abnormal but walks independently 2. Abnormal and dependent on the eventual use of unilateral support 3. Abnormal and dependent on the permanent use of unilateral support 4. Abnormal and dependent on the eventual use of bilateral support 5. Abnormal and dependent on the permanent use of bilateral support 6. Abnormal and dependent on the permanent use of bilateral support and occasional use of a wheelchair (WC) 7. Permanent use of a WC, stands up and remains upright without support 8. Permanent use of a WC, uses arms to stand up and remains upright without support 9. Permanent use of a WC, needs assistance from others to stand up and remains upright with support 10. Permanent use of a WC, unable to stand up, exhibits voluntary movements of the lower limbs 11. Permanent use of a WC, unable to stand up, and does not have any voluntary movements of the lower limbs |
MOTOR SCORE: RUNNINGb 1. Runs 2. Unable to run |
MOTOR SCORE: CLIMBING STAIRSc 1. Climbs 2. Climbs with support 3. Unable to climb |
MOTOR SCORE: JUMPINGd 1. Jumps on one or two feet 2. Jumps only with both feet 3. Jumps only with both feet with hand support 4. Unable to jump |
SPASTICITY SCORE: CLONUSe 1. Absent 2. Only induced by the examiner 3. Spontaneous |
SPASTICITY SCORE: FLEXOR/EXTENSOR SPASMSf 1. Absent 2. Present |
SENSORY SCORE: PARESTHESIASg 1. Absent 2. Present, eventually 3. Present, permanently |
SENSORY SCORE: LUMBAR PAINh 1. Absent 2. Present, eventually 3. Present, permanently |
SENSORY SCORE: LOWER LIMB PAINi 1. Absent 2. Present, eventually 3. Present, permanently |
SPHINCTER SCORE: BLADDER FUNCTIONj 1. Total control 2. Urgency 3. Eventual incontinence or retention 4. Use of permanent catheter or regular use of relieving catheter |
SPHINCTER SCORE: BOWEL FUNCTIONk 1. Normal 2. Constipation 3. Incontinence or total retention; needs manual extraction or enemas |
Total: ____ (0-31) |
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Schmidt, F.R., Coutinho, E.S., Lima, M.A. et al. Performance of the National Institute of Infectious Diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis. J. Neurovirol. 29, 555–563 (2023). https://doi.org/10.1007/s13365-023-01154-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-023-01154-y